Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.
AUTHORS
Roumie
CL ,
Min
JY ,
Greevy
RA ,
Grijalva
CG ,
Hung
AM ,
Liu
X ,
Elasy
T ,
Griffin
MR ,
. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2016 1 25; ().
- PMID: 26811361 [PubMed].
ABSTRACT
Hypoglycemia remains a common life-threatening event associated with diabetes treatment. We compared the risk of first or recurrent hypoglycemia event among metformin initiators who intensified treatment with insulin versus sulfonylurea.
Hypoglycemia remains a common life-threatening event associated with diabetes treatment. We compared the risk of first or recurrent hypoglycemia event among metformin initiators who intensified treatment with insulin versus sulfonylurea.
Tags: Alumni Publications 2016